Inactive Instrument

Company Bausch Health Companies Inc Toronto S.E.

Equities

CA91911K1021

Pharmaceuticals

Business Summary

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Bausch + Lomb/International
47.3 %
4,905 46.4 % 5,596 47.3 % +14.07%
Salix
25.7 %
2,721 25.7 % 3,037 25.7 % +11.61%
International
12.2 %
1,286 12.2 % 1,446 12.2 % +12.38%
Diversified
10.8 %
1,273 12.0 % 1,273 10.8 % -0.04%
Solta Medical
4.0 %
391 3.7 % 468 4.0 % +19.92%

Sales per region

CAD in Million2022Weight2023Weight Delta
United States and Puerto Rico
59.3 %
6,296 59.5 % 7,010 59.3 % +11.35%
Other
11.5 %
1,155 10.9 % 1,365 11.5 % +18.17%
China
5.0 %
538 5.1 % 595 5.0 % +10.70%
Canada
4.2 %
457 4.3 % 494 4.2 % +8.10%
Mexico
3.7 %
359 3.4 % 435 3.7 % +20.95%
Poland
3.6 %
362 3.4 % 431 3.6 % +18.96%
France
2.4 %
264 2.5 % 289 2.4 % +9.29%
Japan
2.2 %
260 2.5 % 262 2.2 % +0.56%
Germany
1.7 %
191 1.8 % 205 1.7 % +7.20%
Russia
1.7 %
236 2.2 % 200 1.7 % -15.23%
United Kingdom
1.4 %
150 1.4 % 169 1.4 % +12.69%
South Korea
1.1 %
100 0.9 % 126 1.1 % +25.22%
Spain
1.1 %
109 1.0 % 124 1.1 % +13.55%
Italy
1.0 %
99 0.9 % 116 1.0 % +17.32%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 51 22-05-23
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer 49 10-12-31
Investor Relations Contact - 17-06-18
Human Resources Officer - 18-12-31
General Counsel - -
Corporate Officer/Principal - 06-12-31
Treasurer 48 -
Corporate Officer/Principal 59 16-08-07

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 08-07-31
Chairman 68 17-05-31
Director/Board Member 35 21-03-16
Director/Board Member 69 22-05-05
Director/Board Member 44 21-03-16
Director/Board Member 76 16-06-13
Director/Board Member 73 16-03-07
Director/Board Member 67 16-07-21
Chief Executive Officer 61 -
Director/Board Member 54 16-06-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 360,989,744 327,190,829 ( 90.64 %) 0 90.64 %

Shareholders

NameEquities%Valuation
Carl Icahn
9.502 %
34,721,118 9.502 % 326 M $
Icahn Associates Holding LLC
9.502 %
34,721,118 9.502 % 326 M $
GoldenTree Asset Management LP
7.565 %
27,644,959 7.565 % 260 M $
Paulson & Co., Inc.
7.235 %
26,439,035 7.235 % 248 M $
Fiduciary Trust Company International
4.324 %
15,801,343 4.324 % 148 M $
National Bank Financial, Inc.
4.283 %
15,649,539 4.283 % 147 M $
13,296,000 3.639 % 125 M $
Healthcare of Ontario Pension Plan Trust Fund
3.558 %
13,000,000 3.558 % 122 M $
RBC Dominion Securities, Inc.
3.214 %
11,743,558 3.214 % 110 M $
Vanguard Fiduciary Trust Co.
3.174 %
11,599,131 3.174 % 109 M $

Holdings

NameEquities%Valuation
310,449,643 88.48% 5,122,419,110 $

Company contact information

Bausch Health Cos., Inc.

2150 St. Elzéar Boulevard West

H7L 4A8, Laval

+514 744 6792

http://www.bauschhealth.com
address Bausch Health Companies Inc

Group companies

NameCategory and Sector
Electronic Components
Medical Specialties